An innovative anti-viral mask, Pro-Larva, has been developed by Pharm2Farm, which kills 99.9% of COVID-19 within 5 minutes of contact. The mask not only protects the wearer but also those around the wearer, using copper nanoparticle technology.
Where Current surgical masks are only effective for approximately 2 hours, the viricidal layer is effective for up to 7 hours. Thus, the Pro-Larva mask will reduce the number of masks required and reduce costs within workplaces.
Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).